AstraZeneca (Heart Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

AstraZeneca (Heart Drug) General Information

Description

Commercialization rights to a portfolio of two heart-related drugs. The portfolio is comprised of Plendil (felodipine), a calcium channel blocker for the treatment of hypertension; and Imdur, an oral extended-release formulation of isosorbide mononitrate (ISMN), indicated for the prevention of angina pectoris due to coronary artery disease. The commercialization rights are for marketing and selling Plendil in China and divestment of the global rights to Imdur outside the U.S.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
China Medical System
Vertical(s)
Life Sciences
Corporate Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Heart Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Heart Drug)‘s full profile, request access.

Request a free trial

AstraZeneca (Heart Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Heart Drug)‘s full profile, request access.

Request a free trial

AstraZeneca (Heart Drug) FAQs

  • Where is AstraZeneca (Heart Drug) headquartered?

    AstraZeneca (Heart Drug) is headquartered in London, United Kingdom.

  • What industry is AstraZeneca (Heart Drug) in?

    AstraZeneca (Heart Drug)’s primary industry is Buildings and Property.

  • Is AstraZeneca (Heart Drug) a private or public company?

    AstraZeneca (Heart Drug) is a Private company.

  • What is the current valuation of AstraZeneca (Heart Drug)?

    The current valuation of AstraZeneca (Heart Drug) is .

  • What is AstraZeneca (Heart Drug)’s current revenue?

    The current revenue for AstraZeneca (Heart Drug) is .

  • Who are AstraZeneca (Heart Drug)’s investors?

    AstraZeneca has invested in AstraZeneca (Heart Drug).

  • When was AstraZeneca (Heart Drug) acquired?

    AstraZeneca (Heart Drug) was acquired on 29-Feb-2016.

  • Who acquired AstraZeneca (Heart Drug)?

    AstraZeneca (Heart Drug) was acquired by China Medical System.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »